Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer.


Journal

European urology
ISSN: 1873-7560
Titre abrégé: Eur Urol
Pays: Switzerland
ID NLM: 7512719

Informations de publication

Date de publication:
06 2020
Historique:
received: 08 02 2020
accepted: 05 03 2020
pubmed: 21 3 2020
medline: 22 6 2021
entrez: 21 3 2020
Statut: ppublish

Résumé

Transurethral resection of bladder tumour is the initial, most critical step in the management of bladder cancer; as such, this is a call to arms for the urological community to it the due diligence it deserves regarding technology and training.

Identifiants

pubmed: 32192815
pii: S0302-2838(20)30146-9
doi: 10.1016/j.eururo.2020.03.005
pii:
doi:

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Pagination

669-670

Informations de copyright

Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Hugh Mostafid (H)

Royal Surrey Hospital, Guildford, UK.

Marko Babjuk (M)

Department of Urology, Hospital Motol, Second Faculty of Medicine, Charles University, Prague, Czech Republic.

Bernard Bochner (B)

Urologic Surgery Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Seth P Lerner (SP)

Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA.

Fred Witjes (F)

Nijmegen Medical Centre, Radboud University, Nijmegen, The Netherlands.

Joan Palou (J)

Department of Urology, Fundacio Puigvert, Universidad Autonoma de Barcelona, Barcelona, Spain.

Morgan Roupret (M)

Department of Urology, Hopital Pitie-Salpetriere, Assistance Publique-Hopitaux de Paris Sorbonne Universitaire, Paris, France.

Sharokh Shariat (S)

Department of Urology and Comprehensive Cancer Centre, Vienna General Hospital, Medical University of Vienna, Vienna, Austria.

Paolo Gontero (P)

Division of Urology, Molinette Hospital, University of Torino School of Medicine, Torino, Italy.

Bas van Rhijn (B)

Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Richard Zigeuner (R)

Department of Urology, Medical University of Graz, Graz, Austria.

Richard Sylvester (R)

EAU Guidelines Office, Amsterdam, The Netherlands.

Eva Comperat (E)

Department of Pathology, Hopital Tenon, Group Hospitalier Est Parisian, Assistance Publique Hopitaux de Paris, Paris, France.

Maximilian Burger (M)

Department of Urology, Caritas St Josef Medical Centre, University of Regensburg, Regensburg, Germany.

Bernard Malavaud (B)

Department of Urology, Institut Universitaire du Cancer, Toulouse, France.

Mark Soloway (M)

Memorial Healthcare System, Aventura, FL, USA.

Stephen Williams (S)

The University of Texas Medical Branch, Galveston, TX, USA.

Peter Black (P)

Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.

Siamak Daneshmand (S)

Institute of Urology, USC/Norris Comprehensive Cancer Center, Los Angeles, CA, USA.

Gary Steinberg (G)

Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.

Maurizio Brausi (M)

Urologia dell'Ospedale di Carpi, Modena, Italy.

Jim Catto (J)

Academic Urology Unit, University of Sheffield, Sheffield, UK.

Ashish M Kamat (AM)

Department of Urology, MD Anderson Cancer Center, Houston, TX, USA. Electronic address: akamat@mdanderson.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH